Bicycle Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $2,920 | $9,977 | $3,708 | $2,676 |
Gross Profit | 2,920 | 9,977 | -52,364 | 481 |
EBITDA | -77,433 | -70,204 | -65,959 | -61,208 |
EBIT | -79,129 | -61,892 | -67,663 | -63,402 |
Net Income | -78,952 | -60,754 | -51,854 | -50,802 |
Net Change In Cash | 2,920 | 9,977 | 3,708 | 2,676 |
Free Cash Flow | -73,284 | -87,307 | -9,764 | -40,267 |
Cash | 721,451 | 792,973 | 879,520 | 890,862 |
Basic Shares | 69,252 | 69,196 | 69,051 | 68,988 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $35,275 | $26,976 | $14,463 | $11,697 |
Gross Profit | -137,691 | -129,520 | -67,146 | -33,183 |
EBITDA | -164,892 | -183,400 | -112,964 | -64,081 |
EBIT | -172,069 | -189,946 | -116,650 | -65,490 |
Net Income | -169,031 | -180,664 | -112,717 | -66,819 |
Net Change In Cash | 35,275 | 26,976 | 14,463 | 11,697 |
Free Cash Flow | -165,959 | -63,557 | -105,098 | -16,824 |
Cash | 879,520 | 526,423 | 339,154 | 438,680 |
Basic Shares | 58,207 | 35,592 | 29,660 | 25,061 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.14 |
2025-03-31 | -$0.88 |
2024-12-31 | -$0.81 |
2024-09-30 | -$0.74 |
